Metabolic dysfunction-associated fibrosis 5 (MAF-5) score predicts liver fibrosis risk and outcome in the general population with metabolic dysfunction
Bron
Gastroenterology - ISSN 0016-5085-167:2 (2024) p. 1-20
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease
Bron
Cell death and differentiation - ISSN 1350-9047- (2024) p. 1-14
MASLD/MASH and type 2 diabetes : two sides of the same coin? From single PPAR to pan-PPAR agonists
Bron
Diabetes research and clinical practice - ISSN 0168-8227-212 (2024) p. 1-11
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease : an individual participant data meta-analysis
Bron
Lancet gastroenterology & hepatology - ISSN 2468-1253-8:8 (2023) p. 704-713
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH : a development and validation study
Bron
Hepatology - ISSN 0270-9139-78:1 (2023) p. 258-271